

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 6.38273121 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.68040679 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.68040679 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.68040679 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.68040679 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.68040679 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.68040679 |
| 8 | natural killer cell mediated cytotoxicity (GO:0042267) | 5.32729248 |
| 9 | natural killer cell mediated immunity (GO:0002228) | 5.32729248 |
| 10 | response to muramyl dipeptide (GO:0032495) | 4.93249566 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.91071918 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.91071918 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.91071918 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.83478495 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.63171930 |
| 16 | negative regulation of mast cell activation (GO:0033004) | 4.60437317 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.55079301 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.51194771 |
| 19 | cell adhesion mediated by integrin (GO:0033627) | 4.41510162 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.22696939 |
| 21 | microglial cell activation (GO:0001774) | 4.22410143 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 4.19168484 |
| 23 | behavioral response to nicotine (GO:0035095) | 4.14097437 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.13409531 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.10545373 |
| 26 | indolalkylamine metabolic process (GO:0006586) | 4.09149750 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.98539598 |
| 28 | tryptophan metabolic process (GO:0006568) | 3.93748741 |
| 29 | virion attachment to host cell (GO:0019062) | 3.91349255 |
| 30 | adhesion of symbiont to host cell (GO:0044650) | 3.91349255 |
| 31 | regulation of integrin activation (GO:0033623) | 3.82141849 |
| 32 | response to peptidoglycan (GO:0032494) | 3.70069238 |
| 33 | I-kappaB phosphorylation (GO:0007252) | 3.69567773 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65543783 |
| 35 | negative regulation of cell killing (GO:0031342) | 3.65543783 |
| 36 | negative regulation of macrophage differentiation (GO:0045650) | 3.65269806 |
| 37 | amine catabolic process (GO:0009310) | 3.60404976 |
| 38 | cellular biogenic amine catabolic process (GO:0042402) | 3.60404976 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.57752356 |
| 40 | response to host immune response (GO:0052572) | 3.57752356 |
| 41 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.53150545 |
| 42 | regulation of antigen processing and presentation (GO:0002577) | 3.52564993 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.47974365 |
| 44 | positive regulation of p38MAPK cascade (GO:1900745) | 3.45544777 |
| 45 | cellular response to exogenous dsRNA (GO:0071360) | 3.41058731 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38961740 |
| 47 | cellular response to ATP (GO:0071318) | 3.37148454 |
| 48 | modulation by symbiont of host cellular process (GO:0044068) | 3.36718375 |
| 49 | negative regulation of granulocyte differentiation (GO:0030853) | 3.36193151 |
| 50 | endosome to melanosome transport (GO:0035646) | 3.32097910 |
| 51 | endosome to pigment granule transport (GO:0043485) | 3.32097910 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.31996259 |
| 53 | response to host defenses (GO:0052200) | 3.31375064 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.31375064 |
| 55 | response to host (GO:0075136) | 3.31375064 |
| 56 | NAD biosynthetic process (GO:0009435) | 3.29357379 |
| 57 | neutrophil activation (GO:0042119) | 3.26200892 |
| 58 | apoptotic cell clearance (GO:0043277) | 3.25107306 |
| 59 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.21482790 |
| 60 | granulocyte activation (GO:0036230) | 3.19397972 |
| 61 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.15224567 |
| 62 | detection of light stimulus involved in visual perception (GO:0050908) | 3.15224567 |
| 63 | positive regulation of prostaglandin secretion (GO:0032308) | 3.12956615 |
| 64 | germinal center formation (GO:0002467) | 3.12356602 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 3.11279360 |
| 66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11279360 |
| 67 | positive regulation of interferon-beta production (GO:0032728) | 3.11132331 |
| 68 | leukocyte mediated cytotoxicity (GO:0001909) | 3.11116141 |
| 69 | ruffle organization (GO:0031529) | 3.07414780 |
| 70 | mature B cell differentiation (GO:0002335) | 3.06438175 |
| 71 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.06041549 |
| 72 | macrophage activation (GO:0042116) | 3.04217521 |
| 73 | cortical actin cytoskeleton organization (GO:0030866) | 3.03470047 |
| 74 | wound healing, spreading of epidermal cells (GO:0035313) | 3.03153257 |
| 75 | positive regulation of protein oligomerization (GO:0032461) | 3.03059764 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00654543 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 2.98641072 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 2.97987739 |
| 79 | lymphangiogenesis (GO:0001946) | 2.96333261 |
| 80 | substrate-dependent cell migration (GO:0006929) | 2.95719853 |
| 81 | adhesion of symbiont to host (GO:0044406) | 2.93477626 |
| 82 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.93412248 |
| 83 | fucose catabolic process (GO:0019317) | 2.91316507 |
| 84 | L-fucose metabolic process (GO:0042354) | 2.91316507 |
| 85 | L-fucose catabolic process (GO:0042355) | 2.91316507 |
| 86 | negative regulation of telomere maintenance (GO:0032205) | 2.87651709 |
| 87 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87015595 |
| 88 | cytokine secretion (GO:0050663) | 2.86057608 |
| 89 | lymphocyte mediated immunity (GO:0002449) | 2.80904355 |
| 90 | pinocytosis (GO:0006907) | 2.80765302 |
| 91 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.80628204 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78680230 |
| 93 | neutrophil mediated immunity (GO:0002446) | 2.78328774 |
| 94 | glycerophospholipid catabolic process (GO:0046475) | 2.78115694 |
| 95 | indole-containing compound metabolic process (GO:0042430) | 2.77913237 |
| 96 | positive regulation of defense response to virus by host (GO:0002230) | 2.77627717 |
| 97 | dendritic cell differentiation (GO:0097028) | 2.75102274 |
| 98 | mature B cell differentiation involved in immune response (GO:0002313) | 2.72961389 |
| 99 | semaphorin-plexin signaling pathway (GO:0071526) | 2.72604193 |
| 100 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.71597306 |
| 101 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.71050650 |
| 102 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.71046914 |
| 103 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70335544 |
| 104 | positive regulation of interleukin-12 production (GO:0032735) | 2.70196301 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67382640 |
| 106 | positive regulation of T cell apoptotic process (GO:0070234) | 2.64879456 |
| 107 | positive regulation of mast cell activation (GO:0033005) | 2.64440530 |
| 108 | lytic vacuole organization (GO:0080171) | 2.64008911 |
| 109 | lysosome organization (GO:0007040) | 2.64008911 |
| 110 | membrane raft organization (GO:0031579) | 2.63916279 |
| 111 | cortical cytoskeleton organization (GO:0030865) | 2.63680304 |
| 112 | myeloid dendritic cell differentiation (GO:0043011) | 2.62729732 |
| 113 | regulation of early endosome to late endosome transport (GO:2000641) | 2.61884380 |
| 114 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.61297420 |
| 115 | positive regulation of heat generation (GO:0031652) | 2.60706039 |
| 116 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.60565704 |
| 117 | regulation of prostaglandin secretion (GO:0032306) | 2.59684032 |
| 118 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.58567076 |
| 119 | negative regulation of interleukin-6 production (GO:0032715) | 2.58122097 |
| 120 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.57802629 |
| 121 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.57774240 |
| 122 | B cell homeostasis (GO:0001782) | 2.57389125 |
| 123 | T cell mediated immunity (GO:0002456) | 2.56985719 |
| 124 | protein polyglutamylation (GO:0018095) | 2.56808164 |
| 125 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56636697 |
| 126 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.56348592 |
| 127 | growth hormone receptor signaling pathway (GO:0060396) | 2.54662239 |
| 128 | positive regulation of fatty acid transport (GO:2000193) | 2.54321244 |
| 129 | NLS-bearing protein import into nucleus (GO:0006607) | 2.53316167 |
| 130 | platelet dense granule organization (GO:0060155) | 2.53055608 |
| 131 | low-density lipoprotein particle clearance (GO:0034383) | 2.51836554 |
| 132 | negative regulation of interleukin-12 production (GO:0032695) | 2.51189520 |
| 133 | protein localization to endosome (GO:0036010) | 2.51130503 |
| 134 | response to ATP (GO:0033198) | 2.50820346 |
| 135 | interferon-gamma secretion (GO:0072643) | 2.50716318 |
| 136 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.50691764 |
| 137 | regulation of interleukin-12 production (GO:0032655) | 2.50315573 |
| 138 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.50055233 |
| 139 | monocyte chemotaxis (GO:0002548) | 2.50040910 |
| 140 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.49598355 |
| 141 | regulation of necroptotic process (GO:0060544) | 2.49197493 |
| 142 | opioid receptor signaling pathway (GO:0038003) | 2.48768173 |
| 143 | regulation of mast cell activation (GO:0033003) | 2.48041837 |
| 144 | B cell mediated immunity (GO:0019724) | 2.46628212 |
| 145 | macroautophagy (GO:0016236) | 2.46493243 |
| 146 | negative regulation of lipid storage (GO:0010888) | 2.46438818 |
| 147 | myeloid cell homeostasis (GO:0002262) | 2.45624890 |
| 148 | aromatic amino acid family catabolic process (GO:0009074) | 2.45281734 |
| 149 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.45086610 |
| 150 | regulation of cholesterol storage (GO:0010885) | 2.44736221 |
| 151 | respiratory burst (GO:0045730) | 2.43972047 |
| 152 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.43750916 |
| 153 | regulation of monocyte chemotaxis (GO:0090025) | 2.43559987 |
| 154 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43557810 |
| 155 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.42764562 |
| 156 | proteoglycan biosynthetic process (GO:0030166) | 2.42519807 |
| 157 | regulation of mononuclear cell migration (GO:0071675) | 2.41570660 |
| 158 | positive regulation of icosanoid secretion (GO:0032305) | 2.40924620 |
| 159 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.40051522 |
| 160 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.38318230 |
| 161 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.38111033 |
| 162 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.37690562 |
| 163 | neuronal action potential (GO:0019228) | 2.34151226 |
| 164 | cellular ketone body metabolic process (GO:0046950) | 2.33993135 |
| 165 | lipopolysaccharide metabolic process (GO:0008653) | 2.33428163 |
| 166 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.33240528 |
| 167 | DNA deamination (GO:0045006) | 2.33238478 |
| 168 | negative regulation of interleukin-1 production (GO:0032692) | 2.32691762 |
| 169 | sulfation (GO:0051923) | 2.32568709 |
| 170 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.31931940 |
| 171 | adenosine receptor signaling pathway (GO:0001973) | 2.31340678 |
| 172 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.30477389 |
| 173 | ganglioside metabolic process (GO:0001573) | 2.29817019 |
| 174 | dermatan sulfate biosynthetic process (GO:0030208) | 2.29711254 |
| 175 | purinergic receptor signaling pathway (GO:0035587) | 2.29458322 |
| 176 | intracellular pH reduction (GO:0051452) | 2.29402630 |
| 177 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.28912150 |
| 178 | blood vessel maturation (GO:0001955) | 2.28615272 |
| 179 | regulation of interleukin-8 secretion (GO:2000482) | 2.27499645 |
| 180 | fucose metabolic process (GO:0006004) | 2.27006348 |
| 181 | response to pheromone (GO:0019236) | 2.25726036 |
| 182 | sphingoid metabolic process (GO:0046519) | 2.25600182 |
| 183 | ubiquinone biosynthetic process (GO:0006744) | 2.25427060 |
| 184 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.25345249 |
| 185 | tooth mineralization (GO:0034505) | 2.24850531 |
| 186 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.24844964 |
| 187 | synaptic transmission, cholinergic (GO:0007271) | 2.24356645 |
| 188 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.23930251 |
| 189 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.23239120 |
| 190 | dermatan sulfate metabolic process (GO:0030205) | 2.22813774 |
| 191 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.22798937 |
| 192 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.22798937 |
| 193 | positive regulation of natural killer cell activation (GO:0032816) | 2.22574100 |
| 194 | negative regulation of monooxygenase activity (GO:0032769) | 2.22221997 |
| 195 | endoderm formation (GO:0001706) | 2.22139927 |
| 196 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.20675970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.49329717 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.46460109 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30317170 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.14538654 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.59307408 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42900534 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.41754173 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27330100 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.26321370 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.16435895 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94233814 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.68554334 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.64013046 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.58623461 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55943416 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45568977 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37001695 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35472322 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32458189 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21647385 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20575415 |
| 22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.15826133 |
| 23 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.14895234 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12228958 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.07605510 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06844299 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04472342 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.94648182 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93411662 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91284078 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91087852 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90304321 |
| 33 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.87443213 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86332836 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.86178454 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81269629 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76970845 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76098113 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.75227110 |
| 40 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74844705 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.72473064 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.70791045 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69989431 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.69758114 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68555481 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68298525 |
| 47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.67588138 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65949627 |
| 49 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64814250 |
| 50 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.64781134 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.63845070 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62546219 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59715969 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58787857 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58438583 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57986873 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57279468 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56379330 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54179457 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.50889431 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46526428 |
| 62 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.46452477 |
| 63 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.45853249 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44296743 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43632859 |
| 66 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.42001638 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41624446 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.41083724 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40600987 |
| 70 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.39417441 |
| 71 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.38469509 |
| 72 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.38469509 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.38298546 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37697197 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36804095 |
| 76 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.36523994 |
| 77 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.35945739 |
| 78 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35262861 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35152219 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.33962929 |
| 81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33677806 |
| 82 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32257893 |
| 83 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32056498 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31602879 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.31544356 |
| 86 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.31424598 |
| 87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31170377 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30238619 |
| 89 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.28037796 |
| 90 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.26661504 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26479363 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26347645 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 1.25196908 |
| 94 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24836562 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24156231 |
| 96 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23881437 |
| 97 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23633492 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23200655 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22850809 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22790949 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.21985339 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21802757 |
| 103 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20959737 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20529417 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20311614 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19487567 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18917650 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18798927 |
| 109 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18715485 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17942745 |
| 111 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17327030 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16140362 |
| 113 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15872199 |
| 114 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.15817127 |
| 115 | MYB_26560356_Chip-Seq_TH2_Human | 1.14949420 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14927133 |
| 117 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14246784 |
| 118 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.14227723 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.13315779 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13303446 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.13009009 |
| 122 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12033949 |
| 123 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11772926 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11667105 |
| 125 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11305911 |
| 126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.10939728 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10868064 |
| 128 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10805847 |
| 129 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10658735 |
| 130 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10485292 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10110360 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09830143 |
| 133 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09393985 |
| 134 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09376740 |
| 135 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09358535 |
| 136 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09358535 |
| 137 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08507188 |
| 138 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.08120034 |
| 139 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07495334 |
| 140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06980964 |
| 141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06980964 |
| 142 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06629010 |
| 143 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06421195 |
| 144 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06126549 |
| 145 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05769856 |
| 146 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05556877 |
| 147 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05431812 |
| 148 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05431812 |
| 149 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.05340478 |
| 150 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04871464 |
| 151 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.04141165 |
| 152 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03917672 |
| 153 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03056900 |
| 154 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.02603725 |
| 155 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02411802 |
| 156 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02017245 |
| 157 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01200486 |
| 158 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00774775 |
| 159 | MAF_26560356_Chip-Seq_TH2_Human | 1.00157652 |
| 160 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99571663 |
| 161 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99297087 |
| 162 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98873347 |
| 163 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.97925616 |
| 164 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97249713 |
| 165 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97179035 |
| 166 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97078589 |
| 167 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.96008986 |
| 168 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95713822 |
| 169 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95252234 |
| 170 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94348749 |
| 171 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.94043338 |
| 172 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.94043338 |
| 173 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.94028165 |
| 174 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93492743 |
| 175 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93198466 |
| 176 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.91073512 |
| 177 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89943729 |
| 178 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88352750 |
| 179 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87476688 |
| 180 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87318658 |
| 181 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86502901 |
| 182 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86255818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.63137156 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.69329866 |
| 3 | MP0004510_myositis | 3.34051909 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.31327829 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.85134170 |
| 6 | MP0003195_calcinosis | 2.84146816 |
| 7 | MP0003950_abnormal_plasma_membrane | 2.72115976 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.70281559 |
| 9 | MP0002254_reproductive_system_inflammat | 2.68474415 |
| 10 | MP0010386_abnormal_urinary_bladder | 2.66423541 |
| 11 | MP0003303_peritoneal_inflammation | 2.65739571 |
| 12 | MP0009840_abnormal_foam_cell | 2.50677454 |
| 13 | MP0003436_decreased_susceptibility_to | 2.45170146 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.42147177 |
| 15 | MP0009278_abnormal_bone_marrow | 2.36059372 |
| 16 | MP0003091_abnormal_cell_migration | 2.32448504 |
| 17 | MP0001542_abnormal_bone_strength | 2.29841485 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.23142247 |
| 19 | MP0006054_spinal_hemorrhage | 2.21171791 |
| 20 | MP0003646_muscle_fatigue | 2.17051603 |
| 21 | MP0005076_abnormal_cell_differentiation | 2.16992304 |
| 22 | MP0000685_abnormal_immune_system | 2.13009259 |
| 23 | MP0002419_abnormal_innate_immunity | 2.11852382 |
| 24 | MP0009764_decreased_sensitivity_to | 2.09180106 |
| 25 | MP0001968_abnormal_touch/_nociception | 2.03456119 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 2.03411757 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 2.01349984 |
| 28 | MP0005595_abnormal_vascular_smooth | 1.96429067 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.93993806 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.92679626 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.91958257 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.90265392 |
| 33 | MP0006082_CNS_inflammation | 1.89228908 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.87313500 |
| 35 | MP0004947_skin_inflammation | 1.84719059 |
| 36 | MP0010307_abnormal_tumor_latency | 1.83300412 |
| 37 | MP0001790_abnormal_immune_system | 1.81424272 |
| 38 | MP0005387_immune_system_phenotype | 1.81424272 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.78852205 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.77160201 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.72670832 |
| 42 | MP0001800_abnormal_humoral_immune | 1.71753820 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.70625707 |
| 44 | MP0004858_abnormal_nervous_system | 1.68222295 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.66601768 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.65857684 |
| 47 | MP0009046_muscle_twitch | 1.64349130 |
| 48 | MP0002736_abnormal_nociception_after | 1.64225587 |
| 49 | MP0000733_abnormal_muscle_development | 1.62505366 |
| 50 | MP0002723_abnormal_immune_serum | 1.62209265 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.61942070 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.60155293 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.60112952 |
| 54 | MP0001958_emphysema | 1.59712441 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.59194359 |
| 56 | MP0005410_abnormal_fertilization | 1.53154862 |
| 57 | MP0004043_abnormal_pH_regulation | 1.52898278 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.52501589 |
| 59 | MP0003448_altered_tumor_morphology | 1.51975492 |
| 60 | MP0000230_abnormal_systemic_arterial | 1.48813252 |
| 61 | MP0001970_abnormal_pain_threshold | 1.48676668 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.48491335 |
| 63 | MP0001819_abnormal_immune_cell | 1.47939704 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.47020563 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.46661756 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.46661756 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.43857455 |
| 68 | MP0002420_abnormal_adaptive_immunity | 1.43545507 |
| 69 | MP0002148_abnormal_hypersensitivity_rea | 1.41488660 |
| 70 | MP0005025_abnormal_response_to | 1.41453517 |
| 71 | MP0005023_abnormal_wound_healing | 1.41410021 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.39511477 |
| 73 | MP0000858_altered_metastatic_potential | 1.36820056 |
| 74 | MP0000604_amyloidosis | 1.36181413 |
| 75 | MP0002006_tumorigenesis | 1.33155540 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.31832486 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.27083067 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.26204894 |
| 79 | MP0000767_abnormal_smooth_muscle | 1.25430873 |
| 80 | MP0002405_respiratory_system_inflammati | 1.24983685 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.22216725 |
| 82 | MP0003279_aneurysm | 1.21944158 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.21044504 |
| 84 | MP0000750_abnormal_muscle_regeneration | 1.20737305 |
| 85 | MP0000371_diluted_coat_color | 1.20481142 |
| 86 | MP0000538_abnormal_urinary_bladder | 1.20243868 |
| 87 | MP0009785_altered_susceptibility_to | 1.19736117 |
| 88 | MP0006276_abnormal_autonomic_nervous | 1.17792867 |
| 89 | MP0010368_abnormal_lymphatic_system | 1.17102769 |
| 90 | MP0002653_abnormal_ependyma_morphology | 1.16863659 |
| 91 | MP0004147_increased_porphyrin_level | 1.14950781 |
| 92 | MP0005671_abnormal_response_to | 1.14950437 |
| 93 | MP0000427_abnormal_hair_cycle | 1.13114029 |
| 94 | MP0003879_abnormal_hair_cell | 1.12021725 |
| 95 | MP0002102_abnormal_ear_morphology | 1.11765749 |
| 96 | MP0003633_abnormal_nervous_system | 1.11174398 |
| 97 | MP0004142_abnormal_muscle_tone | 1.10211901 |
| 98 | MP0002396_abnormal_hematopoietic_system | 1.07464723 |
| 99 | MP0003283_abnormal_digestive_organ | 1.07135849 |
| 100 | MP0005197_abnormal_uvea_morphology | 1.07078564 |
| 101 | MP0003045_fibrosis | 1.07029276 |
| 102 | MP0009745_abnormal_behavioral_response | 1.06377739 |
| 103 | MP0001873_stomach_inflammation | 1.06056494 |
| 104 | MP0001915_intracranial_hemorrhage | 1.05094777 |
| 105 | MP0005310_abnormal_salivary_gland | 1.03999871 |
| 106 | MP0004742_abnormal_vestibular_system | 1.03747272 |
| 107 | MP0000716_abnormal_immune_system | 1.03642187 |
| 108 | MP0002398_abnormal_bone_marrow | 1.00375594 |
| 109 | MP0005621_abnormal_cell_physiology | 0.99505382 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.98575567 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.98198508 |
| 112 | MP0000689_abnormal_spleen_morphology | 0.98095567 |
| 113 | MP0002234_abnormal_pharynx_morphology | 0.95936612 |
| 114 | MP0001663_abnormal_digestive_system | 0.94390469 |
| 115 | MP0005083_abnormal_biliary_tract | 0.92286597 |
| 116 | MP0002572_abnormal_emotion/affect_behav | 0.91123105 |
| 117 | MP0001905_abnormal_dopamine_level | 0.89510967 |
| 118 | MP0004133_heterotaxia | 0.89244417 |
| 119 | MP0001243_abnormal_dermal_layer | 0.89227275 |
| 120 | MP0005503_abnormal_tendon_morphology | 0.89035941 |
| 121 | MP0002722_abnormal_immune_system | 0.89020170 |
| 122 | MP0002272_abnormal_nervous_system | 0.87476187 |
| 123 | MP0008469_abnormal_protein_level | 0.86759219 |
| 124 | MP0001853_heart_inflammation | 0.86120458 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.84566874 |
| 126 | MP0003075_altered_response_to | 0.84490042 |
| 127 | MP0002064_seizures | 0.84344201 |
| 128 | MP0002429_abnormal_blood_cell | 0.84077033 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.83689702 |
| 130 | MP0002229_neurodegeneration | 0.83415291 |
| 131 | MP0002933_joint_inflammation | 0.82830828 |
| 132 | MP0005165_increased_susceptibility_to | 0.79112581 |
| 133 | MP0000249_abnormal_blood_vessel | 0.78099111 |
| 134 | MP0008260_abnormal_autophagy | 0.78074126 |
| 135 | MP0003137_abnormal_impulse_conducting | 0.76312199 |
| 136 | MP0002067_abnormal_sensory_capabilities | 0.75937751 |
| 137 | MP0000343_altered_response_to | 0.75445725 |
| 138 | MP0000920_abnormal_myelination | 0.74430365 |
| 139 | MP0005390_skeleton_phenotype | 0.74356800 |
| 140 | MP0003631_nervous_system_phenotype | 0.73888711 |
| 141 | MP0005084_abnormal_gallbladder_morpholo | 0.73067224 |
| 142 | MP0005508_abnormal_skeleton_morphology | 0.72933166 |
| 143 | MP0005195_abnormal_posterior_eye | 0.72777537 |
| 144 | MP0002277_abnormal_respiratory_mucosa | 0.72299937 |
| 145 | MP0002168_other_aberrant_phenotype | 0.71074015 |
| 146 | MP0002928_abnormal_bile_duct | 0.70225381 |
| 147 | MP0009333_abnormal_splenocyte_physiolog | 0.69639268 |
| 148 | MP0010155_abnormal_intestine_physiology | 0.69148900 |
| 149 | MP0005253_abnormal_eye_physiology | 0.68838421 |
| 150 | MP0005384_cellular_phenotype | 0.68406947 |
| 151 | MP0008007_abnormal_cellular_replicative | 0.68227286 |
| 152 | MP0000627_abnormal_mammary_gland | 0.67544811 |
| 153 | MP0001963_abnormal_hearing_physiology | 0.67089532 |
| 154 | MP0005670_abnormal_white_adipose | 0.66508829 |
| 155 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65672255 |
| 156 | MP0009250_abnormal_appendicular_skeleto | 0.64781682 |
| 157 | MP0004185_abnormal_adipocyte_glucose | 0.64254442 |
| 158 | MP0003828_pulmonary_edema | 0.62890919 |
| 159 | MP0000703_abnormal_thymus_morphology | 0.61483978 |
| 160 | MP0002060_abnormal_skin_morphology | 0.60616021 |
| 161 | MP0001851_eye_inflammation | 0.58534683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.46966521 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 4.41170004 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.25842948 |
| 4 | Mesangial abnormality (HP:0001966) | 4.01395841 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90510907 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90510907 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90510907 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.61434482 |
| 9 | Cerebral aneurysm (HP:0004944) | 3.55179094 |
| 10 | Follicular hyperkeratosis (HP:0007502) | 3.45117736 |
| 11 | Distal lower limb amyotrophy (HP:0008944) | 3.44426151 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 3.44322406 |
| 13 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.44322406 |
| 14 | Hematochezia (HP:0002573) | 3.41929434 |
| 15 | Axonal loss (HP:0003447) | 3.38476819 |
| 16 | Type II lissencephaly (HP:0007260) | 3.32994729 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.31924339 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.31346112 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.31346112 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.25792710 |
| 21 | Myocardial infarction (HP:0001658) | 3.21412073 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.17974420 |
| 23 | Upper limb amyotrophy (HP:0009129) | 3.10496811 |
| 24 | Distal upper limb amyotrophy (HP:0007149) | 3.10496811 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.07874721 |
| 26 | Attenuation of retinal blood vessels (HP:0007843) | 3.06245889 |
| 27 | Pancreatic fibrosis (HP:0100732) | 3.05328375 |
| 28 | Genetic anticipation (HP:0003743) | 3.01647046 |
| 29 | Abolished electroretinogram (ERG) (HP:0000550) | 2.98183149 |
| 30 | Keratoconus (HP:0000563) | 2.97475295 |
| 31 | Increased corneal curvature (HP:0100692) | 2.97475295 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96710091 |
| 33 | Pancreatic cysts (HP:0001737) | 2.93477401 |
| 34 | Congenital stationary night blindness (HP:0007642) | 2.92537724 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.89130037 |
| 36 | Cerebellar dysplasia (HP:0007033) | 2.88585819 |
| 37 | Joint stiffness (HP:0001387) | 2.83136851 |
| 38 | Urethral obstruction (HP:0000796) | 2.78610575 |
| 39 | True hermaphroditism (HP:0010459) | 2.74282110 |
| 40 | Nephronophthisis (HP:0000090) | 2.72127052 |
| 41 | Thick nail (HP:0001805) | 2.68840663 |
| 42 | Pathologic fracture (HP:0002756) | 2.66131660 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.65694919 |
| 44 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.65326606 |
| 45 | Lower limb amyotrophy (HP:0007210) | 2.64858744 |
| 46 | Premature rupture of membranes (HP:0001788) | 2.64836437 |
| 47 | Protruding tongue (HP:0010808) | 2.60304555 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.60149965 |
| 49 | Hand muscle atrophy (HP:0009130) | 2.58816360 |
| 50 | Clumsiness (HP:0002312) | 2.56939069 |
| 51 | Frequent falls (HP:0002359) | 2.53542943 |
| 52 | Tetraparesis (HP:0002273) | 2.52665593 |
| 53 | Disinhibition (HP:0000734) | 2.50726190 |
| 54 | Mutism (HP:0002300) | 2.47881875 |
| 55 | Retinal atrophy (HP:0001105) | 2.43021563 |
| 56 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.40233428 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.39687095 |
| 58 | Difficulty climbing stairs (HP:0003551) | 2.39635420 |
| 59 | Gingivitis (HP:0000230) | 2.39533437 |
| 60 | Inability to walk (HP:0002540) | 2.39515990 |
| 61 | Glomerulonephritis (HP:0000099) | 2.38172632 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.36306667 |
| 63 | Decreased central vision (HP:0007663) | 2.36224298 |
| 64 | Flat capital femoral epiphysis (HP:0003370) | 2.35094592 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.34576160 |
| 66 | Absent frontal sinuses (HP:0002688) | 2.33970498 |
| 67 | Increased connective tissue (HP:0009025) | 2.30941758 |
| 68 | Myositis (HP:0100614) | 2.30408941 |
| 69 | Tubular atrophy (HP:0000092) | 2.30026717 |
| 70 | Increased density of long bones (HP:0006392) | 2.29758262 |
| 71 | Recurrent skin infections (HP:0001581) | 2.29026599 |
| 72 | Bone pain (HP:0002653) | 2.28648590 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.28438157 |
| 74 | Short nail (HP:0001799) | 2.28335102 |
| 75 | Periodontitis (HP:0000704) | 2.27985738 |
| 76 | Global brain atrophy (HP:0002283) | 2.27289054 |
| 77 | Submucous cleft hard palate (HP:0000176) | 2.26829453 |
| 78 | Prostate neoplasm (HP:0100787) | 2.25848052 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24170902 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24170902 |
| 81 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24170902 |
| 82 | Loss of speech (HP:0002371) | 2.22256047 |
| 83 | Premature loss of primary teeth (HP:0006323) | 2.22073173 |
| 84 | Orchitis (HP:0100796) | 2.21727369 |
| 85 | Bulbous nose (HP:0000414) | 2.20956246 |
| 86 | Peritonitis (HP:0002586) | 2.17753827 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17071144 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.17071144 |
| 89 | Retinal dysplasia (HP:0007973) | 2.15303716 |
| 90 | Congenital hepatic fibrosis (HP:0002612) | 2.14889830 |
| 91 | Distal lower limb muscle weakness (HP:0009053) | 2.13641399 |
| 92 | Abnormality of the renal medulla (HP:0100957) | 2.12593228 |
| 93 | Polydipsia (HP:0001959) | 2.12054485 |
| 94 | Abnormal drinking behavior (HP:0030082) | 2.12054485 |
| 95 | Congenital sensorineural hearing impairment (HP:0008527) | 2.08592945 |
| 96 | Recurrent viral infections (HP:0004429) | 2.07817045 |
| 97 | Long toe (HP:0010511) | 2.07377463 |
| 98 | Basal ganglia calcification (HP:0002135) | 2.01552976 |
| 99 | Ovoid vertebral bodies (HP:0003300) | 2.01351084 |
| 100 | Nephritis (HP:0000123) | 2.00864458 |
| 101 | Leukocytosis (HP:0001974) | 1.98889414 |
| 102 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.98787221 |
| 103 | Osteomyelitis (HP:0002754) | 1.98554901 |
| 104 | Mitral valve prolapse (HP:0001634) | 1.98538820 |
| 105 | Colitis (HP:0002583) | 1.97149233 |
| 106 | Macroglossia (HP:0000158) | 1.96765786 |
| 107 | Optic neuritis (HP:0100653) | 1.95081730 |
| 108 | Retrobulbar optic neuritis (HP:0100654) | 1.95081730 |
| 109 | Hyperventilation (HP:0002883) | 1.94420974 |
| 110 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.93896642 |
| 111 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93298701 |
| 112 | Aortic valve stenosis (HP:0001650) | 1.92718256 |
| 113 | Achilles tendon contracture (HP:0001771) | 1.91957283 |
| 114 | Syringomyelia (HP:0003396) | 1.91890799 |
| 115 | Spinal cord lesions (HP:0100561) | 1.91890799 |
| 116 | Broad metatarsal (HP:0001783) | 1.91721065 |
| 117 | Spinal muscular atrophy (HP:0007269) | 1.91536439 |
| 118 | Arterial thrombosis (HP:0004420) | 1.90907450 |
| 119 | Progressive visual loss (HP:0000529) | 1.90669109 |
| 120 | Absent/shortened dynein arms (HP:0200106) | 1.90534838 |
| 121 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.90534838 |
| 122 | Persistence of primary teeth (HP:0006335) | 1.89972768 |
| 123 | Aortic aneurysm (HP:0004942) | 1.89718891 |
| 124 | Cystic liver disease (HP:0006706) | 1.89011998 |
| 125 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88629476 |
| 126 | Dilatation of the ascending aorta (HP:0005111) | 1.88507505 |
| 127 | Severe muscular hypotonia (HP:0006829) | 1.88397929 |
| 128 | Fatigue (HP:0012378) | 1.87425426 |
| 129 | Poor head control (HP:0002421) | 1.86721075 |
| 130 | Chronic hepatic failure (HP:0100626) | 1.85988667 |
| 131 | Upper motor neuron abnormality (HP:0002127) | 1.85700777 |
| 132 | Scapular winging (HP:0003691) | 1.85057598 |
| 133 | Opisthotonus (HP:0002179) | 1.85045892 |
| 134 | Concave nail (HP:0001598) | 1.84554810 |
| 135 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84254952 |
| 136 | Abnormality of alanine metabolism (HP:0010916) | 1.84254952 |
| 137 | Hyperalaninemia (HP:0003348) | 1.84254952 |
| 138 | Progressive cerebellar ataxia (HP:0002073) | 1.83773630 |
| 139 | Abnormality of the vertebral endplates (HP:0005106) | 1.83716392 |
| 140 | Amyloidosis (HP:0011034) | 1.83473923 |
| 141 | Progressive inability to walk (HP:0002505) | 1.83116379 |
| 142 | Spondylolisthesis (HP:0003302) | 1.81853123 |
| 143 | Congenital, generalized hypertrichosis (HP:0004540) | 1.81111975 |
| 144 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.80852103 |
| 145 | Bradycardia (HP:0001662) | 1.77513229 |
| 146 | Adactyly (HP:0009776) | 1.77456567 |
| 147 | Abnormality of the renal cortex (HP:0011035) | 1.76994291 |
| 148 | Cervical subluxation (HP:0003308) | 1.76895786 |
| 149 | Striae distensae (HP:0001065) | 1.76842017 |
| 150 | Disproportionate short-trunk short stature (HP:0003521) | 1.76422947 |
| 151 | Severe visual impairment (HP:0001141) | 1.75707401 |
| 152 | Abnormality of proline metabolism (HP:0010907) | 1.75581959 |
| 153 | Hydroxyprolinuria (HP:0003080) | 1.75581959 |
| 154 | Ulnar bowing (HP:0003031) | 1.75206169 |
| 155 | Tubulointerstitial fibrosis (HP:0005576) | 1.73767231 |
| 156 | Agnosia (HP:0010524) | 1.73708097 |
| 157 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71478967 |
| 158 | Vasculitis (HP:0002633) | 1.70489439 |
| 159 | Neuronal loss in central nervous system (HP:0002529) | 1.70386056 |
| 160 | Sclerocornea (HP:0000647) | 1.70331520 |
| 161 | Interstitial pulmonary disease (HP:0006530) | 1.70104900 |
| 162 | Ankle contracture (HP:0006466) | 1.67114295 |
| 163 | Protrusio acetabuli (HP:0003179) | 1.65436508 |
| 164 | Medial flaring of the eyebrow (HP:0010747) | 1.64686884 |
| 165 | Eosinophilia (HP:0001880) | 1.64112299 |
| 166 | Arterial tortuosity (HP:0005116) | 1.63846084 |
| 167 | Stomatitis (HP:0010280) | 1.63596956 |
| 168 | Aortic regurgitation (HP:0001659) | 1.63327022 |
| 169 | Redundant skin (HP:0001582) | 1.62903291 |
| 170 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62694581 |
| 171 | Dysautonomia (HP:0002459) | 1.61672653 |
| 172 | Retinitis pigmentosa (HP:0000510) | 1.61487891 |
| 173 | Abnormality of dental color (HP:0011073) | 1.61161160 |
| 174 | Albinism (HP:0001022) | 1.60992727 |
| 175 | Prolonged neonatal jaundice (HP:0006579) | 1.60773161 |
| 176 | Irregular vertebral endplates (HP:0003301) | 1.59674141 |
| 177 | Abnormality of binocular vision (HP:0011514) | 1.59385560 |
| 178 | Diplopia (HP:0000651) | 1.59385560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.51069062 |
| 2 | ADRBK2 | 3.99510238 |
| 3 | MAP3K14 | 3.97023761 |
| 4 | TYK2 | 3.26241388 |
| 5 | TTN | 3.21209533 |
| 6 | TBK1 | 3.15607858 |
| 7 | MAP3K13 | 2.74653884 |
| 8 | ACVR1B | 2.62858867 |
| 9 | GRK7 | 2.43705224 |
| 10 | CAMK1D | 2.42669599 |
| 11 | BMPR1B | 2.37676052 |
| 12 | IKBKB | 2.34129324 |
| 13 | RIPK4 | 2.33843889 |
| 14 | TRIB3 | 2.24830653 |
| 15 | KIT | 2.17630998 |
| 16 | TGFBR2 | 1.95071812 |
| 17 | MOS | 1.94391663 |
| 18 | JAK1 | 1.91481302 |
| 19 | PTK6 | 1.91295782 |
| 20 | LIMK1 | 1.90706367 |
| 21 | CHUK | 1.89783332 |
| 22 | CSF1R | 1.87729975 |
| 23 | TGFBR1 | 1.85277625 |
| 24 | WNK4 | 1.83794568 |
| 25 | BCKDK | 1.83440978 |
| 26 | ABL2 | 1.81439132 |
| 27 | PAK4 | 1.81394503 |
| 28 | IRAK3 | 1.81316107 |
| 29 | GRK1 | 1.79284307 |
| 30 | ADRBK1 | 1.78628251 |
| 31 | JAK3 | 1.76536766 |
| 32 | IKBKE | 1.74026179 |
| 33 | CAMK1G | 1.70953588 |
| 34 | INSRR | 1.58113660 |
| 35 | CAMKK2 | 1.55663243 |
| 36 | PKN2 | 1.52603525 |
| 37 | EPHB1 | 1.52201262 |
| 38 | MAP4K2 | 1.49957007 |
| 39 | RPS6KA4 | 1.49153069 |
| 40 | SIK2 | 1.48758272 |
| 41 | NUAK1 | 1.47831618 |
| 42 | CDK12 | 1.45835861 |
| 43 | SCYL2 | 1.45689872 |
| 44 | IRAK4 | 1.43441275 |
| 45 | EPHA2 | 1.42918907 |
| 46 | NEK9 | 1.32206768 |
| 47 | FGR | 1.28560095 |
| 48 | PTK2 | 1.26548604 |
| 49 | PINK1 | 1.23146963 |
| 50 | MAP2K3 | 1.20634791 |
| 51 | RIPK1 | 1.18842996 |
| 52 | LRRK2 | 1.16850010 |
| 53 | BMX | 1.16702118 |
| 54 | PRKD2 | 1.15159746 |
| 55 | TIE1 | 1.14667189 |
| 56 | MAP3K10 | 1.12673539 |
| 57 | TXK | 1.08650696 |
| 58 | STK10 | 1.05180594 |
| 59 | MATK | 1.04878698 |
| 60 | HCK | 1.03668892 |
| 61 | MAP3K3 | 0.99298448 |
| 62 | MUSK | 0.99003026 |
| 63 | CDK6 | 0.97727671 |
| 64 | MYLK | 0.96153343 |
| 65 | TRPM7 | 0.94645945 |
| 66 | WNK3 | 0.92925164 |
| 67 | ERN1 | 0.90760354 |
| 68 | ZAK | 0.90399194 |
| 69 | PIM2 | 0.88870767 |
| 70 | MTOR | 0.86947449 |
| 71 | KDR | 0.86711226 |
| 72 | ZAP70 | 0.86008437 |
| 73 | ICK | 0.85251594 |
| 74 | PAK2 | 0.84509726 |
| 75 | MAPKAPK5 | 0.84255581 |
| 76 | CAMKK1 | 0.82873805 |
| 77 | MAPK13 | 0.82537013 |
| 78 | FLT3 | 0.80093935 |
| 79 | DDR2 | 0.79406750 |
| 80 | TEC | 0.79055922 |
| 81 | NME2 | 0.79047335 |
| 82 | AKT3 | 0.78169224 |
| 83 | RET | 0.77023975 |
| 84 | MAP3K9 | 0.76351388 |
| 85 | PDGFRA | 0.74140555 |
| 86 | STK38 | 0.73749316 |
| 87 | NEK2 | 0.73406594 |
| 88 | MAP2K6 | 0.72421833 |
| 89 | PIK3CG | 0.71820809 |
| 90 | TLK1 | 0.71030746 |
| 91 | MAPKAPK2 | 0.70485222 |
| 92 | MAP3K8 | 0.70414558 |
| 93 | LCK | 0.69877481 |
| 94 | BLK | 0.69292406 |
| 95 | PRKCG | 0.69250848 |
| 96 | STK3 | 0.68694344 |
| 97 | EGFR | 0.68061055 |
| 98 | MAP3K11 | 0.67454572 |
| 99 | TAOK3 | 0.66862094 |
| 100 | CSK | 0.65678285 |
| 101 | JAK2 | 0.65371012 |
| 102 | FGFR4 | 0.64751800 |
| 103 | MAP4K1 | 0.64001339 |
| 104 | MARK3 | 0.63373274 |
| 105 | FES | 0.62755794 |
| 106 | MAP2K7 | 0.60955077 |
| 107 | PDGFRB | 0.59841577 |
| 108 | PTK2B | 0.59740229 |
| 109 | EPHB2 | 0.59596082 |
| 110 | EEF2K | 0.56652355 |
| 111 | PIM1 | 0.56433172 |
| 112 | CDC42BPA | 0.55676313 |
| 113 | TAOK2 | 0.55088069 |
| 114 | ALK | 0.54355031 |
| 115 | RPS6KA2 | 0.53662366 |
| 116 | PAK1 | 0.53425342 |
| 117 | CAMK1 | 0.53285361 |
| 118 | MAPKAPK3 | 0.53138093 |
| 119 | PRKAA2 | 0.52324985 |
| 120 | NTRK1 | 0.51573062 |
| 121 | PRKCE | 0.50606970 |
| 122 | CAMK2A | 0.50275600 |
| 123 | PRKG2 | 0.50252404 |
| 124 | PKN1 | 0.49766244 |
| 125 | CAMK2D | 0.48856941 |
| 126 | KSR2 | 0.47209920 |
| 127 | MELK | 0.46253430 |
| 128 | DAPK3 | 0.45690120 |
| 129 | ABL1 | 0.45278436 |
| 130 | SYK | 0.45190460 |
| 131 | MAP2K1 | 0.43973877 |
| 132 | PNCK | 0.43045658 |
| 133 | GRK5 | 0.42623976 |
| 134 | RPS6KC1 | 0.42124446 |
| 135 | RPS6KL1 | 0.42124446 |
| 136 | CAMK2G | 0.41634051 |
| 137 | PRKCA | 0.41229025 |
| 138 | DAPK2 | 0.41173829 |
| 139 | PAK6 | 0.39671813 |
| 140 | INSR | 0.38446716 |
| 141 | CSNK1G3 | 0.37270675 |
| 142 | PRKCH | 0.37158588 |
| 143 | RPS6KA6 | 0.36209177 |
| 144 | CAMK2B | 0.35581650 |
| 145 | STK4 | 0.35385803 |
| 146 | MAP2K2 | 0.35050757 |
| 147 | ROCK1 | 0.34475438 |
| 148 | GSK3A | 0.33996253 |
| 149 | WNK1 | 0.33895008 |
| 150 | MAPK4 | 0.33831563 |
| 151 | TSSK6 | 0.33271111 |
| 152 | TESK2 | 0.32766295 |
| 153 | PRKCQ | 0.32208740 |
| 154 | TESK1 | 0.31725590 |
| 155 | PDPK1 | 0.30954431 |
| 156 | SRC | 0.30925732 |
| 157 | ERBB4 | 0.30046470 |
| 158 | MAPK15 | 0.30036671 |
| 159 | OXSR1 | 0.30017041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43628999 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27953555 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18255089 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11131546 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.07100054 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.01687321 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.99638866 |
| 8 | Apoptosis_Homo sapiens_hsa04210 | 1.98780022 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.96990541 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92337118 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91606858 |
| 12 | Asthma_Homo sapiens_hsa05310 | 1.89332080 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.88713119 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.85325793 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.84156567 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80833682 |
| 17 | Shigellosis_Homo sapiens_hsa05131 | 1.76033716 |
| 18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.74484560 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.73586612 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.68654281 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.65523808 |
| 22 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.62810691 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61977769 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.61676210 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.61451420 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58682065 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.54339049 |
| 28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50584323 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48307141 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.47578604 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47386206 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.47220079 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.46713190 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.45967964 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45101588 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.42506608 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41950785 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.40819885 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38513482 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38268554 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.35215397 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.35075667 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.34961419 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33456498 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29928420 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29161605 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26589360 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26343041 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.26117658 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25611293 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 1.25057396 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24057351 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22692008 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.22579215 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22012027 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21051963 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20461066 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.19299620 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18618196 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18474957 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18427951 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 1.17268315 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16397144 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 1.14739213 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14706116 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12634460 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.11947425 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.11077965 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09731940 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09692748 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05741532 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05556404 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 1.05300811 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05126206 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 1.03939142 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03346954 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01459434 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 1.00508397 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99052850 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97410700 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97254143 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.97187943 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95679890 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.94943423 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94737163 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.93553454 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91746883 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91606713 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.91007027 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89138363 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.88119025 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86200400 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.85083958 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84993862 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.84153278 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83964469 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83455115 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82992748 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81746736 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78298221 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77286324 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75570450 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72975150 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72916361 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72137488 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72006194 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71993651 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.71802593 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70190238 |
| 110 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68843138 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68179633 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67435323 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67419173 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67361536 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.66728694 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66727219 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.65646229 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64411624 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63643627 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63531013 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63520558 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63222415 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62357476 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.61851245 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61810279 |
| 126 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61638866 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.61096689 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60291954 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60056321 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59419221 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59082796 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59021793 |
| 133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58324533 |
| 134 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58241386 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57145436 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.56872409 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55958518 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55728702 |
| 139 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55574947 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55454000 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | 0.55285613 |
| 142 | Melanoma_Homo sapiens_hsa05218 | 0.54015225 |
| 143 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53928728 |
| 144 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53668067 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53603809 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.53288480 |
| 147 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53131676 |
| 148 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52773231 |
| 149 | Long-term depression_Homo sapiens_hsa04730 | 0.52726551 |
| 150 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51908611 |
| 151 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47863206 |
| 152 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46339031 |
| 153 | Renin secretion_Homo sapiens_hsa04924 | 0.45499600 |
| 154 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44676381 |
| 155 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42622715 |
| 156 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41360699 |
| 157 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39853016 |
| 158 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39601086 |
| 159 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39086830 |
| 160 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37573159 |
| 161 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37136572 |

